Form 4: Accelmed Partners Sells $724,000 Worth of Strata Skin Sciences Shares

Accelmed Partners, a significant shareholder in Strata Skin Sciences, sold 230,573 shares of common stock at $3.14 per share on July 15, 2024.

Summary

• Accelmed Partners, L.P. sold 230,573 shares of Strata Skin Sciences, Inc. (SSKN) common stock on July 15, 2024.
• The sale price was $3.14 per share.
• Following the transaction, Accelmed Partners, L.P. continues to beneficially own 1,441,835 shares indirectly.
• The shares are held directly by Accelmed Partners, L.P. and may be deemed to be beneficially owned indirectly by Accelmed Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a significant shareholder. It doesn't inherently convey positive or negative sentiment, but the market may interpret the sale as a slightly negative signal.

Industry Context

Sales by significant shareholders are common and can be driven by various factors, including portfolio rebalancing or the need for capital. It's important to monitor such transactions to understand potential shifts in investor sentiment and ownership structure.

Stakeholder Impact

• Shareholders may react to the news of Accelmed Partners' share sale.
• The sale could potentially influence the stock price of Strata Skin Sciences.

Key Dates

Keywords

Strata Skin Sciences, SSKN, Accelmed Partners, Share Sale, Beneficial Ownership, Form 4, Securities Transaction